Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Apple Hospitality REIT
APLE
$3.78B
| $1.6M | ﹤0.01% |
137,500
-16,100
| -10% | -$189K |
|
2252
Old Republic International
ORI
$10.3B
| $1.6M | ﹤0.01% |
41,685
-20,400
| -33% | -$768K |
|
2253
State Street SPDR S&P Dividend ETF
SDY
$22.2B
| $1.6M | ﹤0.01% |
11,800
-17,600
| -60% | -$2.33M |
|
2254
Capital Bancorp
CBNK
$621M
| $1.6M | ﹤0.01% |
47,500
+800
| +2% | +$24.5K |
|
2255
Crexendo
CXDO
$218M
| $1.59M | ﹤0.01% |
262,400
+82,000
| +45% | +$428K |
|
2256
Berkshire Hathaway Class B
BRK.B
$1.08T
| $1.59M | ﹤0.01% |
3,268
+1,232
| +61% | +$626K |
|
2257
Peoples Financial Services
PFIS
$718M
| $1.59M | ﹤0.01% |
32,112
-1,800
| -5% | -$83.4K |
|
2258
iShares MSCI USA Value Factor ETF
VLUE
$9.78B
| $1.58M | ﹤0.01% |
14,000
+6,000
| +75% | +$633K |
|
2259
Comstock Holding Companies
CHCI
$167M
| $1.58M | ﹤0.01% |
156,979
+800
| +0.5% | +$7.95K |
|
2260
Gold Royalty Corp
GROY
$736M
| $1.58M | ﹤0.01% |
715,700
-102,500
| -13% | -$180K |
|
|
PPLI
2261
People Inc
PPLI
$3.02B
| $1.57M | ﹤0.01% |
+42,127
| New | +$1.52M |
|
2262
CB Financial Services
CBFV
$190M
| $1.57M | ﹤0.01% |
55,116
+6,217
| +13% | +$177K |
|
2263
Lionsgate Studios
LION
$3.57B
| $1.57M | ﹤0.01% |
+270,272
| New | +$1.81M |
|
2264
MaxCyte
MXCT
$138M
| $1.56M | ﹤0.01% |
717,800
+349,900
| +95% | +$847K |
|
2265
C4 Therapeutics
CCCC
$493M
| $1.56M | ﹤0.01% |
1,093,188
+878,688
| +410% | +$1.28M |
|
2266
American Well
AMWL
$221M
| $1.56M | ﹤0.01% |
175,423
+500
| +0.3% | +$3.57K |
|
|
ATXS
2267
DELISTED
Astria Therapeutics
ATXS
| $1.55M | ﹤0.01% |
289,778
+110,617
| +62% | +$536K |
|
2268
Cato Corp
CATO
$67.3M
| $1.55M | ﹤0.01% |
551,302
-9,200
| -2% | -$24.5K |
|
|
PLYM
2269
DELISTED
Plymouth Industrial REIT
PLYM
| $1.55M | ﹤0.01% |
96,392
-40,820
| -30% | -$638K |
|
2270
Sypris Solutions
SYPR
$49.9M
| $1.54M | ﹤0.01% |
698,821
-12,900
| -2% | -$23.2K |
|
2271
Axogen
AXGN
$2.56B
| $1.54M | ﹤0.01% |
142,000
+80,000
| +129% | +$1.05M |
|
2272
Vanguard Morningstar Large-Cap ETF
VV
$54.9B
| $1.54M | ﹤0.01% |
+5,400
| New | +$1.42M |
|
|
DFSV
2273
Dimensional US Small Cap Value ETF
DFSV
$8.48B
| $1.54M | ﹤0.01% |
52,300
-10,400
| -17% | -$288K |
|
2274
State Street SPDR S&P Bank ETF
KBE
$1.75B
| $1.54M | ﹤0.01% |
+27,600
| New | +$1.44M |
|
2275
Dimensional US Large Cap Value ETF
DFLV
$7.04B
| $1.54M | ﹤0.01% |
+49,500
| New | +$1.47M |
|
Similar funds
Jim Simons's Q2 2025 Portfolio in Review
As of Q2 2025, Jim Simons held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Jim Simons added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Jim Simons's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Jim Simons fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Jim Simons's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Jim Simons opened 612 new positions and closed 496 in Q2 2025.
- Jim Simons's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.